Skip to main content
. 2011 Jul 6;6(7):e21296. doi: 10.1371/journal.pone.0021296

Table 2. Treatment-related Adverse Events (AE).

CTCAE System Organ Class/Preferred Term (MedDRA) N (%) Tot. AE Grade 1 Grade 2 Grade 3
Blood/Lymphatic System Disorders: 1 (0.7)
Blood/lymphatic disorder 1 1
Ear and Labyrinth Disorders: 2 (1.5)
Hearing impaired 1 1
Middle ear inflammation 1 1
Gastrointestinal Disorders: 15 (10.9)
Abdominal pain 5 3 1 1
Constipation 1 1
Diarrhea 1 1
Vomiting 6 5 1
Other 2 2
General Disorders: 50 (36.5)
Fatigue 17 14 2 1
Fever 2 1 1
Flu like symptoms 4 3 1
Irritability 4 3 1
Pain 5 2 1 2
Other 18 8 10
Immune System Disorders: 2 (1.5)
Allergic reaction 2 1 1
Infections and Infestations: 24 (24.2)
Eye infection 1 1
Otitis media 4 2 2
Rhinitis infective 3 3
Sinusitis 2 2
Skin infection 1 1
Upper respiratory infection 1 1
Other 12 12
Injury, Poisoning and Procedural Complications: 5 (3.6)
Fall 1 1
Fracture 4 1 3
Investigations: 1 (0.7)
Neutrophil count decreased 1 1
Metabolism and nutrition disorders: 1 (0.7)
Dehydration 1 1
Musculoskeletal and connective tissue disorders: 2 (1.5)
Pain in extremity 1 1
Other 1 1
Nervous System Disorders: 6 (4.4)
Headache 1 1
Lethargy 2 1 1
Tremor 3 3
Psychiatric disorders: 4 (2.9)
Mania 1 1
Restlessness 1 1
Other 2 1 1
Respiratory, thoracic and mediastinal disorders: 19 (13.9)
Allergic rhinitis 1 1
Cough 7 5 2
Nasal congestion 4 3 1
Pneumonitis 4 4
Sore throat 1 1
Other 2 1 1
Skin and subcutaneous tissue disorders: 5 (3.6)
Rash maculo-papular 2 1 1
Other 3 3

Events are listed alphabetically with percentages indicating percent of total AEs. Grading is according to standard Common Terminology Criteria for Adverse Events (CTCAE) grading.